ACUTE MYOCARDIAL INFARCTION: REPERFUSION TREATMENT
暂无分享,去创建一个
[1] Johan Herlitz,et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[2] A. M. Skene,et al. TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.
[3] R. Gibbons,et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. , 1998, JAMA.
[4] C. Pfafferott,et al. Direct percutaneous transluminal coronary angioplasty in acute myocardial infarction. Predictors of short-term outcome and the impact of coronary stenting. Study Group of The Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK). , 1998, European heart journal.
[5] J S Martin,et al. A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial Infarction , 1996 .
[6] R. Califf. Ten years of benefit from a one-hour intervention. , 1998, Circulation.
[7] G. Tognoni,et al. Patterns of practice for acute myocardial infarction in a population from ten countries , 1999, European Journal of Clinical Pharmacology.
[8] H. White,et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction , 1996, BMJ.
[9] R. Califf,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[10] J. Blankenship,et al. Cardiovascular complications of thrombolytic therapy in patients with a mistaken diagnosis of acute myocardial infarction. , 1989, Journal of the American College of Cardiology.
[11] R. Califf,et al. Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other Countries: Results From the GUSTO Trial , 1995 .
[12] J. O’Keefe,et al. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. , 1999, Journal of the American College of Cardiology.
[13] G. Knatterud,et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. , 2002, JAMA.
[14] K. Bailey,et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.
[15] R. Schiele,et al. Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[16] S. Greenhouse,et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial , 1999 .
[17] P. Armstrong,et al. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. , 2001 .
[18] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[19] M. Schwaiger,et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. , 2000, The New England journal of medicine.
[20] J. Burchenal,et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. , 1998, Circulation.
[21] R. Califf,et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. , 1999, Circulation.
[22] W. O’Neill. Coronary thrombosis during acute myocardial infarction: Roberts was right! , 1998, The American journal of cardiology.
[23] B. Brodie,et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction. , 2000, Circulation.
[24] R. Califf,et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. , 1997, Circulation.
[25] J. Gore,et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). , 1998, Journal of the American College of Cardiology.
[26] F Rovelli,et al. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators. , 1998, Circulation.
[27] M. Morice,et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.
[28] G. Stone,et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. , 1998, Journal of the American College of Cardiology.
[29] J. Ferrières,et al. Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. , 1997, Journal of the American College of Cardiology.
[30] Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994, The Lancet.
[31] Bruce R. Brodie,et al. Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .
[32] J. Birkhead. Thrombolytic treatment for myocardial infarction: an examination of practice in 39 United Kingdom hospitals. Myocardial Infarction Audit Group. , 1997, Heart.
[33] G. Hanania,et al. [Therapeutic strategies in acute myocardial infarction. Results of STIM 93 registry]. , 1996, Archives des maladies du coeur et des vaisseaux.
[34] B. Brodie,et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. , 1998, Journal of the American College of Cardiology.
[35] J. Reiber,et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.
[36] J. Herlitz,et al. Long-Term Survival after Development of Acute Myocardial Infarction Has Improved after a More Widespread Use of Thrombolysis and Aspirin , 1999, Cardiology.
[37] M. Morice,et al. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. , 2001, European heart journal.
[38] R. Boyle. Immediate angioplasty in the United Kingdom. , 1995, British heart journal.
[39] C. Werter,et al. Aspirin Versus Coumadin in the Prevention of Reocclusion and Recurrent Ischemia After Successful Thrombolysis: A Prospective Placebo‐Controlled Angiographic Study Results of the APRICOT Study , 1993, Circulation.
[40] L. Bolognese,et al. RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.
[41] H. S,et al. Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock , 2000 .
[42] E. Antman,et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. , 1999, Circulation.
[43] Yuan Zhang,et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. , 1998, Circulation.
[44] R. Schiele,et al. Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty , 1999, Heart.
[45] J. W. Kennedy,et al. Combined thrombolytic and platelet glycoprotein IIb/IIIa inhibitor therapy for acute myocardial infarction: will pharmacological therapy ever equal primary angioplasty? , 1999, Circulation.
[46] Y. Taniyama,et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. , 1996, Circulation.
[47] Richard P. Lewis,et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[48] J. Mifune,et al. Intracoronary aspiration thrombectomy for acute myocardial infarction. , 1998, The American journal of cardiology.
[49] J. Ottervanger,et al. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction. , 2000, European heart journal.
[50] H. White. Future of reperfusion therapy for acute myocardial infarction , 1999, The Lancet.
[51] H. Suryapranata,et al. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. , 1998, Journal of the American College of Cardiology.
[52] D. Ketley,et al. Thrombolytic eligibility in acute myocardial infarction patients admitted to Norwegian hospitals. , 1997, International journal of cardiology.
[53] A. Vado,et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. , 1998, Journal of the American College of Cardiology.
[54] M. Simoons,et al. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.
[55] Frans Van de Werf,et al. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.
[56] W. Parmley. Cost-effectiveness of reperfusion strategies. , 1999, American heart journal.
[57] H. Hooi. Review of Emergency Department thrombolytic therapy and changes in inpatient mortality of acute myocardial infarction on the NSW Central Coast 1986 to 1994-96. , 1999, Australian and New Zealand journal of medicine.
[58] J. Wardrope,et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. , 1999, Journal of accident & emergency medicine.
[59] J. J. Griffin,et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.
[60] B. Brodie. When should patients with acute myocardial infarction be transferred for primary angioplasty? , 1997, Heart.
[61] Eric J. Topol,et al. Illusion of Reperfusion Does Anyone Achieve Optimal Reperfusion During Acute Myocardial Infarction? , 1993, Circulation.
[62] H. Pereira,et al. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial , 2001, The Lancet.
[63] R. Califf. Glycoprotein IIb/IIIa blockade and thrombolytics: early lessons from the SPEED and GUSTO IV trials. , 1999, American heart journal.
[64] The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.
[65] R. Schiele,et al. [Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany]. , 1999, Zeitschrift fur Kardiologie.
[66] F. Zijlstra. Acute myocardial infarction: primary angioplasty , 2001, Heart.
[67] J. Rawles. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). , 1994, Journal of the American College of Cardiology.
[68] W. Roberts,et al. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: a study of 107 necropsy patients. , 1972, The American journal of medicine.
[69] K. Beatt,et al. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. , 1997, The New England journal of medicine.